Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251526 Methods Related to Wound Healing
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251524 Use of cytokine levels in intravenous immunoglobulin treatment of alzheimer's disease
10/04/2012US20120251523 Methods of Modulating TGFbeta Signaling
10/04/2012US20120251522 Targeted delivery of therapeutic agents with lyophilized matrices
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases
10/04/2012US20120251490 Compositions And Methods For Immunotherapy
10/04/2012US20120251485 Antibody targeting osteoclast-related protein siglec-15
10/04/2012US20120251457 Methods and compositions for modulating adipocyte function
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012US20120251441 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
10/04/2012US20120251439 Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis
10/04/2012CA2837122A1 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
10/04/2012CA2831935A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
10/04/2012CA2831907A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
10/04/2012CA2831867A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
10/04/2012CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012CA2831732A1 Methods of administering beta7 integrin antagonists
10/04/2012CA2831667A1 Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
10/04/2012CA2831454A1 Modulators of plexin b2 activity
10/04/2012CA2831426A1 Methods for increasing efficacy of folr1 cancer therapy
10/04/2012CA2831294A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012CA2831247A1 Cancer immunopotentiating agent containing rankl antagonist
10/04/2012CA2831126A1 Treatment of dermatological pathologies
10/04/2012CA2831111A1 Cd37-binding molecules and immunoconjugates thereof
10/04/2012CA2830806A1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
10/04/2012CA2830538A1 Anti - sclerostin antibody crystals and formulations thereof
10/04/2012CA2830442A1 Antibodies directed against icos and uses thereof
10/04/2012CA2830305A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012CA2829105A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012CA2827787A1 Anticoagulant antidotes
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505209A1 Fcgamma-RIIB-specific antibodies and methods of the use thereof
10/03/2012EP2505208A1 Vaccine against Pasteurellaceae
10/03/2012EP2505205A1 Anti-PDGFR Alpha Antibodies
10/03/2012EP2505200A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of scleroderma
10/03/2012EP2505189A1 Stabilizing alkylglycoside compositions and method thereof
10/03/2012EP2505058A1 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
10/03/2012EP2504363A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
10/03/2012EP2504358A2 T cell receptors specific for immunodominant ctl epitopes of hcv
10/03/2012EP2504032A2 Antagonists of il-6 to prevent or treat thrombosis
10/03/2012EP2504031A2 Antibodies to il-6 and use thereof
10/03/2012EP2504030A2 Antagonists of il-6 to raise albumin and/or lower crp
10/03/2012EP2504029A1 Compositions, methods and uses for expression of enterobacterium-associated peptides
10/03/2012EP2504028A2 Simultaneous inhibition of pd-l1/pd-l2
10/03/2012CN1972714B Methods of treating autoimmune and inflammatory diseases
10/03/2012CN1950100B Multi-component biological transport systems
10/03/2012CN1946425B Target for B-cell disorders
10/03/2012CN1909923B Monoparamunity inducers based on attenuated rabbit myxoma viruses
10/03/2012CN1890266B Antibodies
10/03/2012CN1771053B Immunoglobulin formulation and method of preparation thereof
10/03/2012CN1729013B Broad spectrum anti-viral therapeutics and prophylaxis
10/03/2012CN102713623A Detection of early-stage pancreatic adenocarcinoma
10/03/2012CN102712945A Methods and compositions for the treatment of proliferative and pathogenic diseases
10/03/2012CN102712934A Recombinant adenovirus having anti-angiogenesis activity
10/03/2012CN102712931A Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
10/03/2012CN102712930A Porcine torque teno virus vaccines and diagnosis
10/03/2012CN102712923A Anti-iga1 antibody
10/03/2012CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
10/03/2012CN102712909A System for the heterologous expression of a viral protein in a ciliate host cell
10/03/2012CN102712908A Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection
10/03/2012CN102712907A Recombinant measles virus useful as bivalent vaccine against measles and malaria infection
10/03/2012CN102712695A Biological inhibitors of ROR1 capable of inducing cell death
10/03/2012CN102712693A Porphyromonas gingivalis polypeptides
10/03/2012CN102712684A The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
10/03/2012CN102712680A Modified steptococcus pneumonia pneumolysin (PLY) polypeptides
10/03/2012CN102711833A Pharmaceutical formulation for proteins
10/03/2012CN102711830A Tumor tissue based biomarkers for bevacizumab combination therapies
10/03/2012CN102711829A Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
10/03/2012CN102711828A Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
10/03/2012CN102711827A Methods and compositions for diagnosis and prognosis of renal injury and renal failure
10/03/2012CN102711826A Methods and compositions for modulating HEPSIN activation of macrophage-stimulating protein
10/03/2012CN102711825A Dosage regimen for administering an EpCAMxCD3 bispecific antibody
10/03/2012CN102711824A Vaccines directed to Langerhans cells
10/03/2012CN102711823A Methods of treatment using anti-oxidized LDL antibodies
10/03/2012CN102711822A Dosage regimen for administering a CD19xCD3 bispecific antibody
10/03/2012CN102711821A Therapeutic methods and compositions
10/03/2012CN102711820A Methods and compositions for treatment of pulmonary fibrotic disorders
10/03/2012CN102711819A Therapy for enteric infections
10/03/2012CN102711818A Anti-RSV Immunogens and Methods of Immunization
10/03/2012CN102711817A Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of DNA and chimeric virus vaccines
10/03/2012CN102711816A Detection of a circovirus in calves suffering from bovine neonatal pancytopenia
10/03/2012CN102711815A Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/03/2012CN102711814A Chimeric factor h binding proteins (FHBP) and methods of use
10/03/2012CN102711813A Anticoagulant antidotes
10/03/2012CN102711812A Vaccine for treatment of tautopathy
10/03/2012CN102711811A Antibody mimetic scaffolds
10/03/2012CN102711810A Antibody Fc mutants with ablated effector functions
10/03/2012CN102711809A Combination therapy of cancer with anti-endoglin antibodies and anti-VEGF agents
10/03/2012CN102711791A HIV related peptides combination or fusion for use in HIV vaccine composition or as diagnostic means
10/03/2012CN102711787A PAR1 antagonists for use in the treatment or prevention of influenza virus type A infections
10/03/2012CN102711773A Inhibitors for growth hormone and related hormones, and methods of use thereof
10/03/2012CN102711772A Anti-neoplastic uses of artemin antagonists
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102707063A Function of mini-chromosome maintenance complex component in disease diagnosis and prevention of systemic lupus erythematosus
10/03/2012CN102703505A Co-expressed brucella recombinant adenovirus as well as preparation method and use thererof
10/03/2012CN102703393A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
10/03/2012CN102703390A Grass carp hemorrhage antigenic protein, preparation method and application thereof
1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 1823